Cargando…

Inflammation Meets Metabolism: Roles for the Receptor for Advanced Glycation End Products Axis in Cardiovascular Disease

Fundamental modulation of energy metabolism in immune cells is increasingly being recognized for the ability to impart important changes in cellular properties. In homeostasis, cells of the innate immune system, such as monocytes, macrophages and dendritic cells (DCs), are enabled to respond rapidly...

Descripción completa

Detalles Bibliográficos
Autores principales:	Senatus, Laura, MacLean, Michael, Arivazhagan, Lakshmi, Egaña-Gorroño, Lander, López-Díez, Raquel, Manigrasso, Michaele B., Ruiz, Henry H., Vasquez, Carolina, Wilson, Robin, Shekhtman, Alexander, Gugger, Paul F., Ramasamy, Ravichandran, Schmidt, Ann Marie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232874/ https://www.ncbi.nlm.nih.gov/pubmed/34178389 http://dx.doi.org/10.20900/immunometab20210024

Ejemplares similares

Receptor for Advanced Glycation End Products (RAGE) and Mechanisms and Therapeutic Opportunities in Diabetes and Cardiovascular Disease: Insights From Human Subjects and Animal Models
por: Egaña-Gorroño, Lander, et al.
Publicado: (2020)

Diabetes and Cardiovascular Complications: The Epidemics Continue
por: López-Díez, Raquel, et al.
Publicado: (2021)

Glycation and a Spark of ALEs (Advanced Lipoxidation End Products) – Igniting RAGE/Diaphanous-1 and Cardiometabolic Disease
por: Arivazhagan, Lakshmi, et al.
Publicado: (2022)

DIAPH1 mediates progression of atherosclerosis and regulates hepatic lipid metabolism in mice
por: Senatus, Laura, et al.
Publicado: (2023)

Neuronal–glial communication perturbations in murine SOD1(G93A) spinal cord
por: MacLean, Michael, et al.
Publicado: (2022)

Small Molecule Inhibition of Ligand-Stimulated RAGE-DIAPH1 Signal Transduction
por: Manigrasso, Michaele B., et al.
Publicado: (2016)

Disruption of the productive encounter complex results in dysregulation of DIAPH1 activity
por: Theophall, Gregory G., et al.
Publicado: (2023)

The RAGE/DIAPH1 Signaling Axis & Implications for the Pathogenesis of Diabetic Complications
por: Ramasamy, Ravichandran, et al.
Publicado: (2022)

Soluble Receptor for Advanced Glycation End Products (sRAGE) Isoforms Predict Changes in Resting Energy Expenditure in Adults with Obesity during Weight Loss
por: Popp, Collin J, et al.
Publicado: (2022)

Association study of lipoprotein(a) genetic markers, traditional risk factors, and coronary heart disease in HIV-1-infected patients
por: Egaña-Gorroño, Lander, et al.
Publicado: (2012)

Receptor for advanced glycation end products axis in critically ill patients
por: Ingels, C, et al.
Publicado: (2014)

Accelerated fracture healing in mice lacking the 5-lipoxygenase gene
por: Manigrasso, Michaele B, et al.
Publicado: (2010)

Contributions of the receptor for advanced glycation end products axis activation in gastric cancer
por: Rojas, Armando, et al.
Publicado: (2023)

The AGE-RAGE Axis: Implications for Age-Associated Arterial Diseases
por: Senatus, Laura M., et al.
Publicado: (2017)

Allograft inflammatory factor-1-like is not essential for age dependent weight gain or HFD-induced obesity and glucose insensitivity
por: Parikh, Dippal, et al.
Publicado: (2020)

The Receptor for Advanced Glycation End Products (RAGE) Specifically Recognizes Methylglyoxal-Derived AGEs
por: Xue, Jing, et al.
Publicado: (2014)

Deletion of the Receptor for Advanced Glycation End Products Reduces Glomerulosclerosis and Preserves Renal Function in the Diabetic OVE26 Mouse
por: Reiniger, Nina, et al.
Publicado: (2010)

Advanced Glycation End Products and Psoriasis
por: Maurelli, Martina, et al.
Publicado: (2023)

Receptor of advanced glycation end-products axis and gallbladder cancer: A forgotten connection that we should reconsider
por: Rojas, Armando, et al.
Publicado: (2022)

Insulin/IGF Axis and the Receptor for Advanced Glycation End Products: Role in Meta-inflammation and Potential in Cancer Therapy
por: Vella, Veronica, et al.
Publicado: (2023)

Hesperetin treatment attenuates glycation of lens proteins and advanced‑glycation end products generation
por: Doki, Yuri, et al.
Publicado: (2023)

Cholesterol efflux responds to viral load and CD4 counts in HIV+ patients and is dampened in HIV exposed
por: Tort, Olivia, et al.
Publicado: (2018)

Dietary Advanced Glycation End Products and Aging
por: Luevano-Contreras, Claudia, et al.
Publicado: (2010)

Advanced Glycation End Products and Diabetic Complications
por: Singh, Varun Parkash, et al.
Publicado: (2014)

Advanced Glycation End Products in the Pathogenesis of Psoriasis
por: Papagrigoraki, Anastasia, et al.
Publicado: (2017)

Toxicity of advanced glycation end products (Review)
por: Kuzan, Aleksandra
Publicado: (2021)

Advanced Glycation End Products in Health and Disease
por: Reddy, V. Prakash, et al.
Publicado: (2022)

The Role of Advanced Glycation End Products on Dyslipidemia
por: Vekic, Jelena, et al.
Publicado: (2023)

Microglia RAGE exacerbates the progression of neurodegeneration within the SOD1(G93A) murine model of amyotrophic lateral sclerosis in a sex-dependent manner
por: MacLean, Michael, et al.
Publicado: (2021)

A Receptor of the Immunoglobulin Superfamily Regulates Adaptive Thermogenesis
por: del Pozo, Carmen Hurtado, et al.
Publicado: (2019)

Advanced-glycation end-products axis: A contributor to the risk of severe illness from COVID-19 in diabetes patients
por: Rojas, Armando, et al.
Publicado: (2021)

Receptor for advanced glycation end-products axis and coronavirus disease 2019 in inflammatory bowel diseases: A dangerous liaison?
por: Rojas, Armando, et al.
Publicado: (2021)

Differential MicroRNA Expression Profile between Stimulated PBMCs from HIV-1 Infected Elite Controllers and Viremic Progressors
por: Egaña-Gorroño, Lander, et al.
Publicado: (2014)

The Receptor for Advanced Glycation End Products (RAGE) and the Lung
por: Buckley, Stephen T., et al.
Publicado: (2010)

Role of advanced glycation end products in cellular signaling()
por: Ott, Christiane, et al.
Publicado: (2014)

Vascular Effects of Dietary Advanced Glycation End Products
por: Stirban, Alin, et al.
Publicado: (2015)

Involvement of advanced glycation end‐products in ‘hyperglycemic memory’
por: Nishikawa, Takeshi, et al.
Publicado: (2015)

Advanced Glycation End Products, Diabetes, and Bone Strength
por: Yamamoto, Masahiro, et al.
Publicado: (2016)

Association of advanced glycation end products in Dupuytren disease
por: Takase, Fumiaki, et al.
Publicado: (2018)

Advanced Glycation End-Products in Skeletal Muscle Aging
por: Olson, Lucas C., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nrdfmkjn4arkesk6luudbf8fbs